Live Analytics
Comments 0
Oxford Vaccine Approved Analytics Table
Income Estimates for Oxford Vaccine Approved
Based on this YouTube video's total view count of 196K views and industry-standard rates, the estimated total earning is $137 - $393 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Oxford Vaccine Approved
Explore Oxford Vaccine Approved with 196,374 views, 7,495 likes, and 3,073 comments. Experience the impact of this video content that has captured audience attention.
In the next few months, UK Cases, + 53,135 Deaths, + 414 ChAdOx1 Three weeks for good level of immunity After this people were not hospitalised One dose can prevent serious disease Day 22 to 3 months = 70% to 80% Three billion doses of the vaccine 30 supply agreements and partner networks Medicines and Healthcare products Regulatory Agency (MHRA) Has approved two full doses of the Oxford-AstraZeneca vaccine Not enough clear data to approve the half-dose, full-dose idea First doses, Monday, 4th January Pfizer 21 days is not the minimum gap, get more people protected quicker Doctors can decide to give to pregnant and breast feeding women People with allergies can also be considered Joint Committee on Vaccination and Immunisation Give as many people as possible their first dose of vaccine Give as many vulnerable people some protection from Covid-19 Second dose, 4 to 12 weeks Second dose, longer term protection. Oxford already working on flexibility Oxford/AstraZeneca Vaccine MHRA, Medicines and Healthcare Products Regulatory Agency Fast-track rolling review of the vaccine since November Enters stage 4 on approval Pre-orders EU, 400 million doses UK, 100 million US, 300 million China, 200 million Japan, 120 million Brazil, 100 million Mexico, 77 million Chile, 14,4 million Indonesia, 100 million Australia, 33.6 million Egypt 30 million Argentina 32 million Ecuador 5 million Canada 20 million Argentina and Mexico to produce for Latin America Vaccines alliance for poorer countries, 300 million COVAX, 170 million Three billion doses in 2021 Cost £2 Transport / storage Fridge temperatures Lasts six months when refrigerated at 38–46°F (2–8°C) Efficacy Pascal Soriot, winning formula 62% 70% 90% 100% Strong response in older adults Manufacturing Keele, UK Belgium India, Serum Institute, 1 billion doses Melbourne, Australia Thailand, South East Asia Netherlands and Germany Across Europe Shenzhen, China US Albuquerque, New Mexico Maryland Russia Mexico UK, 100 million Four million ready to go Fifteen million ready to put into vials Mass rollout starts 4th January One million people per week Mass rollout Important that no screening is required Reactogenicity does not appear to be affected by the presences of antibodies to coronavirus. US Mr. Biden, 100 million shots in first 100 days Published evidence base AZ press release https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html Oxford vaccine, home site https://www.ovg.ox.ac.uk The Oxford Coronavirus Site https://www.research.ox.ac.uk/Area/coronavirus-research/vaccine The Jenner Institute https://www.jenner.ac.uk
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

